Contraceptive Market Size, Share & Trends Analysis Report By Product( Contraceptive Drugs(Contraceptive Pills, Patch, Injectables), Contraceptive Devices(Condoms(Male Condoms, Female Condoms), Subdermal Implants, IUDs(Copper IUDs, Hormonal IUDs), Vaginal Rings, Diaphragm), By Region, And Segment Forecasts, 2025-2034

Report Id: 1494 Pages: 180 Published: 15 April 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Global Contraceptive Market Size is valued at USD 32.5 Billion in 2024 and is predicted to reach USD 69.0 Billion by the year 2034 at a 7.9% CAGR during the forecast period for 2025-2034.

The use of contraception has increased, which has improved health outcomes, such as maternal and newborn mortality, and reduced the risk of STDs. Additionally, it is projected that an increase in the number of gynecologists who support these contraceptive methods for birth control would fuel business expansion in the coming years. The market projections for contraceptives consider factors such as rising awareness of modern contraceptives, rising use of secure and reliable oral pills, and health concerns associated with teen pregnancies. Female contraceptives currently dominate the market, but as more men use condoms, the demand for male contraceptives will rise.

Contraceptive Market

Serious adverse effects include liver diseases, gallbladder illness, heart attacks, and blood clots in the legs. Over the foreseeable period, sales will be constrained by these contraceptive-related side effects. The market may be expanding due to various issues, such as increased consumer knowledge of STDs, unwanted pregnancies, and population control. These factors will cause the need for contraceptives to skyrocket, especially in emerging nations. There is a considerable likelihood that the market will expand thanks to the arrival of new vendors and the growing accessibility of sophisticated contraception techniques greatly. Retail pharmacies will continue to dominate the industry due to manufacturers' improved supply chain networks.

Market Segmentation:

The contraceptive market is segmented into Products (drugs and devices). Based on drugs, the market is segmented into oral contraceptive pills, injectable contraceptives and topical contraceptives. Based on devices, the contraceptive market is segmented into condoms (male, female), diaphragms, contraceptive sponges, vaginal rings, subdermal implants and intra-uterine devices (copper, hormonal).

Based on contraceptive drugs, the contraceptive pills segment is a major contributor to the Contraceptive market.

The market's leading segment is contraceptive pills. The main purposes of contraception pills are to prevent unintended pregnancies, regulate birth rates, and reduce the risk of sexually transmitted diseases. As a result, it will increase in the years to come. Additionally, rising contraceptive use among young women and higher education levels supports the growth of the contraceptive drugs market.

The vaginal ring segment witnessed growth at a rapid rate

The vaginal ring segment is predicted to develop significantly during the forecast period. The segment is growing due to factors including cost-effectiveness and long product life cycles. The availability of new goods and the simplicity of using vaginal rings are anticipated to increase demand for these birth control methods.

The North American contraceptive market holds a significant revenue share in the region.

The North American Contraceptive market is expected to register the highest market share. Favourable government programs, a high proportion of unwanted pregnancies, a rise in the prevalence of sexually transmitted illnesses, etc. The U.S. government has launched several education campaigns about family planning and contraception, which have boosted the sector's income. In the United States, there are many unwanted pregnancies. Besides, Asia Pacific had a substantial share of the Contraceptive market. The region's demand for contraceptives is expected to grow due to increased government activities. The market in the Asia Pacific is also anticipated to be driven by an increase in unwanted pregnancies and improved family planning awareness.

Competitive Landscape

Some major key players in the Contraceptive market are 

  • Bayer AG
  • China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu)
  • Cupid Ltd.
  • Helm AG
  • Church & Dwight
  • Organon Group Of Companies
  • Pfizer Inc.
  • Viatris (Mylan)
  • Abbvie, Inc.
  • Afaxys, Inc.
  • Agile Therapeutics
  • Janssen Pharmaceuticals, Inc.
  • Veru, Inc.
  • Others

Contraceptive Market Report Scope

Report Attribute Specifications
Market Size Value In 2024 USD 32.5 Billion 
Revenue Forecast In 2034 USD 69.0 Billion
Growth Rate CAGR CAGR of 7.9% from 2025 to 2034
Quantitative Units Representation of revenue in US$ Mn, and CAGR from 2025 to 2034
Historic Year 2021 to 2024
Forecast Year 2025-2034
Report Coverage The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends
Segments Covered By Product (Drugs and devices)
Regional Scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country Scope U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia
Competitive Landscape Bayer AG; China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu); Cupid Ltd.; Helm AG; Church & Dwight; Organon Group Of Companies; Pfizer Inc.; Viatris (Mylan); Abbvie, Inc.; Afaxys, Inc.; Agile Therapeutics; Janssen Pharmaceuticals, Inc.; Veru, Inc.
Customization Scope Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.
Pricing And Available Payment Methods Explore pricing alternatives that are customized to your particular study requirements.

Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Contraceptive Market Snapshot

Chapter 4. Global Contraceptive Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis

5.1. by Product Type & Market Share, 2024 -2034

5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021-2034 for the following by Product Type:

5.2.1. Contraceptive Drugs

5.2.1.1. Contraceptive Pills

5.2.1.2. Patch

5.2.1.3. Injectables

5.2.2. Contraceptive Devices

5.2.2.1. Condoms

5.2.2.1.1. Male Condoms

5.2.2.1.2. Female Condoms

5.2.2.2. Subdermal Implants

5.2.2.3. IUDs

5.2.2.3.1. Copper IUDs

5.2.2.3.2. Hormonal IUDs

5.2.2.4. Vaginal Rings

5.2.2.5. Diaphragm

Chapter 6. Contraceptive Market Segmentation 2: Regional Estimates & Trend Analysis

6.1. North America

6.1.1. North America Contraceptive Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034

6.1.2. North America Contraceptive Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034

6.2. Europe

6.2.1. Europe Contraceptive Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034

6.2.2. Europe Contraceptive Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034

6.3. Asia Pacific

6.3.1. Asia Pacific Contraceptive Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034

6.3.2. Asia Pacific Contraceptive Market Revenue (US$ Million) Estimates and Forecasts by country,2021-2034

6.4. Latin America

6.4.1. Latin America Contraceptive Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034

6.4.2. Latin America Contraceptive Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034

6.5. Middle East & Africa

6.5.1. Middle East & Africa Contraceptive Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034

6.5.2. Middle East & Africa Contraceptive Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034

Chapter 7. Competitive Landscape

7.1. Major Mergers and Acquisitions/Strategic Alliances

7.2. Company Profiles

7.2.1. Bayer AG

7.2.2. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu)

7.2.3. Cupid Ltd.

7.2.4. Helm AG

7.2.5. Church & Dwight

7.2.6. Organon Group Of Companies

7.2.7. Pfizer Inc.

7.2.8. Viatris (Mylan)

7.2.9. Abbvie, Inc.

7.2.10. Afaxys, Inc.

7.2.11. Veru, Inc.

7.2.12. Agile Therapeutics

7.2.13. Janssen Pharmaceuticals, Inc.

7.2.14. Other Prominent Players

Market Segmentation

By Products

  • Contraceptive Drugs
    • Contraceptive Pills
    • Patch
    • Injectables
  • Contraceptive Devices
    • Condoms
      • Male Condoms
      • Female Condoms
    • Subdermal Implants
    • IUDs
      • Copper IUDs
      • Hormonal IUDs
    • Vaginal Rings
    • Diaphragm


By Region-

North America-

  • The US
  • Canada

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa
Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
5659
Security Code field cannot be blank!

Frequently Asked Questions

Global Contraceptive Market Size is valued at USD 32.5 Billion in 2024 and is predicted to reach USD 69.0 Billion by the year 2034

Global Contraceptive Market expected to grow at a 7.9% CAGR during the forecast period for 2025-2034

Bayer AG; China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu); Cupid Ltd.; Helm AG; Church & Dwight; Organon Group Of Companies; Pfizer Inc.; Ot

Product (Drugs and devices) are the key segments of the Contraceptive Market.

North America region is leading the Contraceptive Market.
Get Sample Report Enquiry Before Buying